DCGI intensifies crackdown on GLP-1 drug misuse, sales and misleading ads

India's drug regulator is cracking down on illegal sales and promotion of GLP-1 weight loss drugs. Inspections are underway across the country targeting pharmacies, wholesalers, and clinics. The regulator warns of strict action, including license cancellation, for non-compliance. These drugs are only approved for prescription by specialists. The intensified surveillance will continue to ensure ethical practices and patient safety.